跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
UVADEX methoxsalen 200 microgram/10 mL concentrated injection for extracorporeal circulation via photopheresis vial - TGA Drug Approval Details
Approvals
/
TGA
/
UVADEX methoxsalen 200 microgram/10 mL concentrated injection for extracorporeal circulation via photopheresis vial
Approved
STANDARD
UVADEX methoxsalen 200 microgram/10 mL concentrated injection for extracorporeal circulation via photopheresis vial
Ikaria Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
f5d40d9edccda2a9
Company
Ikaria Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
f5d40d9edccda2a9
Product Name
UVADEX methoxsalen 200 microgram/10 mL concentrated injection for extracorporeal circulation via photopheresis vial
Artg Id
308832
Artg Name
UVADEX methoxsalen 200 microgram/10 mL concentrated injection for extracorporeal circulation via photopheresis vial
Sponsor
Ikaria Australia Pty Ltd
Company Detail Path
/organization/ikaria-australia-pty-ltd
Artg Date
2019-09-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/f3ebd7753a4914f9be894ed10f39acde.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2e98b92b2f51d642cc0ef2012637ad52.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
f5d40d9edccda2a9
Type
Standard
Back to TGA Approvals